Applied DNA Sciences (APDN) Receives $3.6M in Net Proceeds from Warrant Exercise
Get Alerts APDN Hot Sheet
Join SI Premium – FREE
Applied DNA Sciences, Inc. (NASDAQ: APDN) announced that it has received approximately $3.6 million in net proceeds following an exercise of Series B warrants by an institutional investor in the Company.
The Series B warrants exercised were issued in connection with a public offering that closed on August 8, 2022. Each Series B warrant entitles its owner to purchase one share of common stock in the Company at a per share price of $4.00 until September 8, 2023. 2.1 million Series B warrants associated with the August 8, 2022, offering remain outstanding. Series A warrants were also issued in connection with the public offering that closed on August 8, 2022. All 3.0 million Series A warrants remain outstanding until August 9, 2027.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Hilton Grand Vacations (HGV) Appoints Dan Mathewes as CFO and President, Dusty Tonkin as EVP, Chief Sales & Marketing Officer
- Autolus Therapeutics (AUTL) Announces 33.33M Share Offering by Selling Stockholders
- EverCommerce (EVCM) Appoints Ellora Sengupta as CIO
Create E-mail Alert Related Categories
Corporate NewsRelated Entities
TwitterSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!